MCM
EXAS

Manchester Capital Management’s Exact Sciences EXAS Stock Holding History

Manchester Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-16
Closed -$1.63K – 1340
2025
Q4 		$1.63K Buy
16
+14
+700% +$1.12K ﹤0.01% 1060
2025
Q3 		$110 Hold
2
– – ﹤0.01% 1278
2025
Q2 		$107 Hold
2
– – ﹤0.01% 1190
2025
Q1 		$87 Hold
2
– – ﹤0.01% 1159
2024
Q4 		$113 Hold
2
– – ﹤0.01% 1140
2024
Q3 		$137 Hold
2
– – ﹤0.01% 1153
2024
Q2 		$85 Hold
2
– – ﹤0.01% 1140
2024
Q1 		$139 Hold
2
– – ﹤0.01% 1017
2023
Q4 		$148 Hold
2
– – ﹤0.01% 983
2023
Q3 		$137 Hold
2
– – ﹤0.01% 978
2023
Q2 		$188 Buy
+2
New +$156 ﹤0.01% 935
2021
Q1 		– Sell
-3
Closed – – 686
2020
Q4 		$0 Hold
3
– – ﹤0.01% 753
2020
Q3 		$0 Buy
+3
New +$259 ﹤0.01% 593
2019
Q2 		– Sell
-453
Closed -$39K – 583
2019
Q1 		$39K Buy
+453
New +$38.6K 0.01% 435

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Manchester Capital Management's EXAS Position: Q1 2026 in Review

Manchester Capital Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 16 shares — an estimated $1.63K sold.

Manchester Capital Management first reported a position in EXAS in Q1 2019 and held it in 14 quarters. The position peaked at $39K in Q1 2019. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Manchester Capital Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Manchester Capital Management sold 16 Exact Sciences shares in Q1 2026, an estimated $1.63K.
  • Manchester Capital Management first reported a position in Exact Sciences in Q1 2019 and held it in 14 quarters.
  • Manchester Capital Management's Exact Sciences position peaked at $39K in Q1 2019.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Manchester Capital Management's 13F filing for Q1 2026, filed 11 May 2026.